Literature DB >> 31686968

Distribution patterns of torpedo maculopathy: Further evidence of a congenital retinal nerve fiber layer-driven etiology.

Parker J Williams1, Sherveen Salek1, Robert A Prinzi2, Chris Bergstrom3, G Baker Hubbard1.   

Abstract

With fewer than 100 peer-reviewed cases reported in the world to date, the underlying etiology of torpedo maculopathy has remained elusive. In this literature review, we provide new evidence to better support, reject and unify claims regarding cause, diagnosis, and proper clinical management of this disease. We reviewed 44 case reports and case series, which included 77 patients (after exclusions). We additionally introduced 3 new cases from our clinical practice for a total of 80 cases. Ages at presentation ranged from 6 months old to 73 years old (mean: 24.2 years old). The nasal aspects of torpedo maculopathy lesions pointed toward the optic disc and localized to a kite-shaped region of the temporal macula, correlating with the anatomic junction of the superior arcuate, inferior arcuate, and papillomacular bundles of retinal nerve fiber layer distribution. No patterns were observed among the temporal aspects of the lesions. These findings support a congenital etiology of torpedo maculopathy and a possible influence of the retinal nerve fiber layer in the development of mature retinal pigment epithelium.
© 2019 The Authors.

Entities:  

Keywords:  BCVA, best corrected visual acuity; CHRPE, congenital hypertrophy of the retinal pigment epithelium; Congenital; Distribution; Embryology; Hypopigmentation; IOP, intraocular pressure; Nerve fiber layer; OCT, optical coherence tomography; RPE, retinal pigment epithelium; Torpedo

Year:  2019        PMID: 31686968      PMCID: PMC6819754          DOI: 10.1016/j.sjopt.2019.07.010

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


Introduction

In 1993, the term torpedo maculopathy was introduced by Mark J Daily to describe a characteristic torpedo-shaped, presumably congenital lesion of the retinal pigment epithelium (RPE) that generally localized in the temporal macula. A similar lesion was described by Roseman and Gass as early as 1992. Since then, numerous reports have been added to the literature, but sample sizes have been relatively small and disjointed, warranting a more comprehensive review. Herein we present 3 new cases of torpedo maculopathy in aggregate with 77 previously reported cases to better elucidate etiological cause, diagnostic characteristics, and clinical management recommendations.

Methods

All known peer-reviewed case reports of clinical torpedo maculopathy from October 1992 to October 2017 were obtained from PubMed, Google Scholar, and previously published reference lists. Search queries included: “torpedo”, “torpedo maculopathy”, “paramacular coloboma”, “hypopigmented nevus”, and “albinotic spot”. Macular colobomas and lesions associated with known global syndromes were not included. These reports were reviewed for age, race, eye affected, shape, location, pigmentation, imaging performed, and exam notes. Four reports were suspected to be misidentified and one report repeated a previously described case. All four cases are included in Table 1 but excluded from the analysis.
Table 1

Quantitative and qualitative data from all patients reviewed.

# of casesAgeGenderEyeNasal aspectPigment Present?Temporal aspectPigment Present?DirectionOCT CavitationOCT Excavation
Rigotti et al. [17]3Child?OSTemporal parafoveaTemporal maculaYHorizontal
???Temporal to foveaTemporal maculaHorizontal
???Temporal to foveaTemporal maculaHorizontal
Barbazetto et al. [18]110FODTemporal perifoveaTemporal peripheryAngled superiorlyYY
Kara et al. [19]10.5MODTemporal parafoveaTemporal maculaYHorizontal
Shields et al. [20]23FODInferotemporal parafoveaTemporal maculaYHorizontal
11FOSTemporal parafoveaTemporal maculaYAngled superiorly
Golchet et al. [1]1333FOSFoveolaTemporal maculaYAngled superiorlyYY
18MOSFoveolaTemporal maculaYAngled superiorlyY
1MOS???
7MOSTemporal parafoveaTemporal maculaYHorizontal
8FOD???
9MODTemporal maculaTemporal maculaHorizontal
13MODTemporal foveaTemporal maculaYHorizontal
14FOS???
20FODInferotemporal perifoveaInferotemporal maculaYAngled superiorly
24FOD???
25MOD???
33FOS???
68FOD???
Roseman and Gass. [2]112MOSSuperotemporal parafoveaTemporal maculaHorizontal
Pian et al. [52]359MOSInferior parafoveaTemporal maculaYHorizontal
63MODTemporal parafoveaTemporal maculaYAngled superiorly
63MOSTemporal parafoveaTemporal maculaYHorizontal
Trevino et al. [8]125FODTemporal perifoveaTemporal maculaYHorizontalY
022FODFoveolaYTemporal maculaYHorizontaln/an/a
Dolz-Marco et al. [22]17MOSFar temporal maculaTemporal peripheryHorizontalY
Nicolau et al. [23]130FODTemporal parafoveaTemporal maculaYAngled superiorly
Cullen et al. [24]110MODFoveolaTemporal maculaYHorizontal
Richez et al.[11]01.5?OUTemporal maculaeYTemporal maculaeYHorizontaln/an/a
Suárez et al. [25]14FODInferior maculaInferotemporal maculaAngled superiorlyY
Villegas et al. [15]1??ODTemporal perifoveaTemporal maculaYHorizontal
Wong et al. [26]514FODTemporal foveaTemporal maculaAngled superiorlyY
15MOSTemporal perifoveaTemporal maculaYAngled superiorly
37FOSTemporal parafoveaTemporal maculaYHorizontal
59MODTemporal maculaTemporal maculaYHorizontalYY
73FODTemporal parafoveaTemporal maculaYHorizontalY
Giannakaki-Zimmerman et al. [27]48FODSuperotemporal parafoveaSuperotemporal maculaYAngled inferiorlyY
13FODFoveolaTemporal maculaYHorizontalY
37FODTemporal parafoveaTemporal maculaYHorizontalY
32FOD???
Rohl et al.[12]010MOSTemporal perifoveaYTemporal maculaYHorizontaln/an/a
Makino et al.[13]08MODTemporal and Inferotemporal maculaYTemporal peripheryYHorizontaln/an/a
Güven et al. [28]110MODInferotemporal parafoveaInferotemporal maculaAngled superiorly
Merle et al. [29]170?OSTemporal parafoveaTemporal maculaYHorizontal
Angioï-Duprez et al. [30]118FOSFoveolaTemporal maculaYHorizontal
Bedar et al. [31]17MODTemporal perifoveaTemporal maculaYHorizontalYY
Hansen et al. [32]112MOSTemporal perifoveaTemporal maculaAngled superiorlyYY
Su et al. [33]138FODTemporal perifoveaTemporal maculaYHorizontal
Sanabria et al. [21]212FODTemporal ParafoveaTemporal maculaHorizontal
13FOSInferotemporal ParafoveaTemporal maculaYAngled superiorlyYY
Papastefanou et al. [34]224MOSTemporal parafoveaTemporal maculaYHorizontalYY
57FOSTemporal parafoveaTemporal maculaYHorizontalYY
Jurjevic et al. [10]320FOSInferotemporal perifoveaInferotemporal maculaYAngled superiorlyYY
49FODSuperotemporal parafoveaSuperotemporal maculaHorizontalYY
34FODTemporal foveaTemporal maculaYHorizontalY
Mercan et al. [35]161MODFoveolaTemporal maculaYAngled superiorlyYY
Schuerch et al. [36]23FODSuperotemporal parafoveaSuperotemporal maculaYAngled inferiorly
36FODTemporal perifoveaTemporal maculaYAngled superiorly
Pilotto et al. [37]14FODTemporal foveaTemporal maculaYHorizontal
Dutra-Medeiros et al. [38]15FODTemporal foveaTemporal maculaYHorizontal
Buzzonetti et al. [39]16MOSNasal foveaTemporal maculaHorizontalYY
Tsang et al. [40]318FOSSuperior foveaTemporal maculaYHorizontal
5FODTemporal perifoveaTemporal maculaYAngled superiorly
25FOSTemporal parafoveaTemporal maculaHorizontal
Shields, Shields.[41]0n/an/an/aREPEAT CASEn/an/an/an/an/an/a
Bhatt et al. [42]121MOSFoveolaTemporal maculaHorizontal
Thomas et al. [43]18FOSFoveolaTemporal maculaYHorizontalYY
De Manuel-Triantafilo et al. [44]24MODTemporal foveaTemporal maculaHorizontal
25FOSSuperotemporal perifoveaSuperotemporal maculaYAngled superiorlyY
Teitelbaum et al. [45]2??ODTemporal maculaTemporal macula?Horizontal
??OSTemporal perifoveaTemporal maculaYHorizontal
Iaboni et al. [46]121FOSInferotemporal perifoveaInferotemporal maculaAngled superiorlyY
Hamm et al. [47]160FODTemporal parafoveaTemporal maculaYAngled superiorlyYY
Ali et al. [48]219FODSuperotemporal parafoveaTemporal maculaYAngled superiorlyYY
46FODTemporal parafoveaTemporal maculaYAngled superiorly
Cherney. [49]4??ODTemporal maculaTemporal maculaYHorizontal
7MOSTemporal maculaTemporal maculaYAngled superiorly
22FOSSubfovealTemporal parafoveaYHorizontal
??ODTemporal parafoveaTemporal maculaHorizontal
Stoyukhina et al. [50]112?ODSuperior parafoveaSuperotemporal maculaYHorizontalY
de Bats et al. [51]135MODSuperotemporal parafoveaTemporal maculaYHorizontalYY
Patient 1 (This paper)15FOSSuperior parafoveaSuperotemporal maculaYHorizontalYY
Patient 2 (This paper)154MOSTemporal parafoveaTemporal maculaAngled superiorly
Patient 3 (This paper)116FODInferotemporal parafoveaInferotemporal maculaHorizontal

Bold text indicates cases that were excluded.

Quantitative and qualitative data from all patients reviewed. Bold text indicates cases that were excluded. Fundus imaging was utilized to gather qualitative information. Preference was given to color fundus photography. After data collection and analysis were complete, the nasal-most points of the lesion origins were plotted on individual reference fundus photographs of a normal left and right eye. This was done using relative measurements between the temporal optic disc margin, the central fovea, and the superior and inferior arcades. Finally, the individual images were aggregated into a single distribution map image of the left and right eyes. This aggregation method helped reduce the bias associated with the manual transfer of this data.

Results

We reviewed 44 previous reports that included 77 distinct cases of torpedo maculopathy after exclusions (4). We additionally introduced 3 new cases for a total of 80 unique cases of torpedo maculopathy (Fig. 1). Age at presentation ranged from 6 months old to 73 years old (mean 24.2 years). Out of 78 cases reporting eye affected, 45 were right eyes and 33 were left eyes. The only bilateral case was excluded due to diagnostic inconstancy with the given diagnosis based on the clinical imaging provided and a failure to rule out salient inflammatory etiologies. No correlations with race were apparent as patients were reported in a wide variety of countries throughout Europe, North America, South America, Africa, and Asia.
Fig. 1

A. Patient 1 color fundus photo of torpedo maculopathy originating in the superonasal macula of the left eye. B. Patient 1 OCT revealing retinal nerve fiber layer irregularity, mild choroidal excavation, and cavitation resembling subretinal fluid at the level of the RPE and outer retina. C. Patient 2 color fundus photo of choroidal melanoma of the right eye. D. Patient 2 color fundus photo of a small temporal torpedo lesion in the left eye. E. Patient 3 laser scanning pseudo-color image of torpedo maculopathy with a satellite lesion in the right eye. F. Patient 3 autofluorescence image showing hypoautofluorescence corresponding to the torpedo lesion. G. Patient 3 OCT revealing mild disorganization at the level of the ellipsoid zone and RPE.

There were 67 cases deemed to have sufficient photographic evidence for qualitative review. We generated a right eye and a left eye distribution pattern of these nasal aspects of torpedo maculopathy which revealed a horizontal kite-shaped pattern in both distribution maps (Fig. 2). The temporal aspect distributions did not produce any remarkable pattern. Analysis of the prior case reports revealed that torpedo maculopathy does not always point toward the fovea. However, in all 67 cases, the nasal aspect of the torpedo lesions pointed toward the disc. Relative hyperpigmentation of the temporal lesion aspect was seen in 51 cases, but relative hyperpigmentation of the nasal aspect was not seen.
Fig. 2

A. Right eye distribution map of 38 nasal torpedo maculopathy origins transposed on a normal reference eye. B. Left eye distribution map of 29 nasal torpedo maculopathy origins transposed on a normal reference left eye.

Optical coherence tomography (OCT) was reported for 51 patients. Of these, 28 cases revealed a cavitation resembling subretinal fluid, and 19 cases reported retinochoroidal excavation. There were 14 cases that reported visual field defects on ancillary testing. Only 1 case reported associated choroidal neovascular membrane requiring treatment with a single series of injections. No clinically significant changes were observed in cases reporting long-term follow-up.

Discussion

Torpedo maculopathy is a rare diagnosis that is ophthalmoscopically characterized as a horizontal, oval-shaped area of hypopigmentation localized to the temporal macula. The etiology of this condition is not well understood as of yet. However, we hope that our findings, in combination with this literature review, may help unify the known clinical features of this rare diagnosis and aid in clinical management. Our first case was a 5-year-old African American girl who was referred to our center for incidental retinal findings on a routine exam. Best-corrected visual acuity (BCVA) measured 20/50 in the right eye and 20/25 in the left eye. The right eye was undergoing regular patching for refractive amblyopia at the time of the visit. Intraocular pressure (IOP) was normal. A review of the patient’s medical history revealed a full-term birth complicated by maternal type 1 diabetes. The patient was evaluated by genetics, who diagnosed diabetic embryopathy in association with patent ductus arteriosus, a ventricular septal defect, and an imperforate anus. Slit-lamp exam was unremarkable except for ptosis of both upper lids. Fundus exam revealed a unilateral ovoid-shaped area of hypopigmentation localized in the superior and superotemporal macula of the left eye. The lesion originated nasal to the fovea and extended laterally into the superotemporal macula (Fig. 1). An OCT was obtained which revealed underlying cavitation and excavation at the level of the ellipsoid zone, RPE, and choroid, as well as mild intraretinal schisis and a retinal nerve fiber layer defect above the nasal aspect of the lesion (Fig. 1). A. Patient 1 color fundus photo of torpedo maculopathy originating in the superonasal macula of the left eye. B. Patient 1 OCT revealing retinal nerve fiber layer irregularity, mild choroidal excavation, and cavitation resembling subretinal fluid at the level of the RPE and outer retina. C. Patient 2 color fundus photo of choroidal melanoma of the right eye. D. Patient 2 color fundus photo of a small temporal torpedo lesion in the left eye. E. Patient 3 laser scanning pseudo-color image of torpedo maculopathy with a satellite lesion in the right eye. F. Patient 3 autofluorescence image showing hypoautofluorescence corresponding to the torpedo lesion. G. Patient 3 OCT revealing mild disorganization at the level of the ellipsoid zone and RPE. Our second case was a 54-year-old Caucasian male who was referred for a concerning lesion in the right eye. BCVA measured 20/40 in the right eye and 20/20 in the left eye. The patient reported a history of pigmentary glaucoma that was treated with peripheral iridotomy in both eyes. IOP was normal. Past medical history was only remarkable for hypertension. Slit-lamp exam was unremarkable. Fundus exam revealed a pigmented mass with orange pigment along the inferotemporal arcade of the right eye and an incidental torpedo-shaped hypopigmented lesion located in the temporal macula of the left eye. The patient was diagnosed with malignant melanoma and treated with brachytherapy of the right eye. The patient had multiple unremarkable Humphrey visual fields of the left eye. Our third case was a 16-year-old Caucasian girl who presented for an annual eye exam to get new glasses. BCVA measured 20/20 in both eyes. IOP was normal. Past medical history was unremarkable. Her eye exam was normal except for a torpedo-shaped lesion and an additional trailing satellite lesion in the inferotemporal macula of the right eye (Fig. 1). Fundus autofluorescence revealed hypoautofluorescence corresponding to the lesion. An OCT was performed which revealed irregularity at the level of the ellipsoid zone and the RPE (Fig. 1). Confrontation visual fields were unremarkable. A. Right eye distribution map of 38 nasal torpedo maculopathy origins transposed on a normal reference eye. B. Left eye distribution map of 29 nasal torpedo maculopathy origins transposed on a normal reference left eye. In all three cases, the torpedo lesions were asymptomatic and incidentally discovered on exam. All three cases remained stable at 3-month follow-up. The lesion shape and relative location were variable in all three cases. Patient 2 had numerous normal Humphrey visual field 24-2 tests. The other two patients had no formal visual field testing. Autofluorescence imaging on Patient 3 revealed hypoautofluorescence corresponding to the shape of the lesion and its associated satellite lesion. OCT on Patient 1, revealed a cavitary excavation of the outer retina, RPE, and choroid, which resembled subretinal fluid. The lesion observed in Patient 1 also atypically extended into the superonasal macula which allowed for better visualization of a disruption of unknown significance in the overlying retinal nerve fiber layer. This nasal macular location has not been reported previously to our knowledge. Great advancements in our understanding of ocular embryology have been made with advanced imaging modalities, animal models, and stem cells; however, the specifics of development and differentiation of the RPE and neural retina in human models are not fully understood and are constantly evolving.[3], [4], [5], [6] It has long been accepted that the presence of pigmentation in developing RPE indicates differentiation of the RPE cell type. However, recent evidence of continuing polarity interactions between RPE and neural retinal cells during early differentiation suggests that the presence of pigmentation may not signify fully mature RPE. Relatedly, we believe that the distribution patterns of torpedo maculopathy suggest a correlation between the development of retinal nerve fiber layer and the development of mature RPE. Torpedo maculopathy is presumed to be a congenital lesion of the RPE, which is supported by numerous clinical observations, including presentation in infancy and lesion stability of over long-term follow-up. Torpedo maculopathy lesions characteristically present with decreased or absent autofluorescence which may support not only loss of RPE pigmentation, but also an overall loss of RPE functionality. Additionally, torpedo maculopathy consistently localizes to the temporal macula which may support a congenital etiology with a conserved mechanism. Review of the literature revealed multiple correlations that further support a congenital etiology. First, every lesion reviewed pointed toward the optic disc. Second, lesion angularity relative to the horizon ranged from perfectly horizontal to superiorly tilted toward the superior aspect of the disc, which is consistent with the slight downwardly-sloped distribution of the horizontal raphe of the retinal nerve fiber layer (Fig. 3). Third, although the temporal aspects of torpedo maculopathy did not produce any recognizable distribution pattern, the nasal aspects localized to a single well-defined kite-shaped region at the junction of the superior arcuate, inferior arcuate and papillomacular bundles of the retinal nerve fiber layer (Fig. 2). According to retinal laser ellipsometry, this kite-shaped region is also associated with relatively low retinal nerve fiber layer density, which may explain the consistent localization of torpedo maculopathy. Based on this data, we suspect a developmental association between the retinal nerve fiber layer and developing RPE.
Fig. 3

Schematic of the retinal nerve fiber layer. Reprinted with permission of Robert N. Weinreb, MD.

Schematic of the retinal nerve fiber layer. Reprinted with permission of Robert N. Weinreb, MD. Fundus autofluorescence and fluorescein angiography maintained a characteristic appearance in all reported cases of torpedo maculopathy. Autofluorescence imaging showed hypoautofluorescence corresponding to the hypopigmented lesion area, and fluorescein angiography revealed a corresponding hyperfluorescent window defect without leakage. These findings were consistent across all lesions reviewed and may indicate a loss of functional RPE. OCT scans of the torpedo lesions were variable. The outer retina, RPE and choroid were all affected, but to differing degrees along a spectrum. The inner retina was found to be largely preserved with the exception of the retinal nerve fiber layer, which appeared relatively thin directly above the nasal aspect of the lesion in some cases. With that being said, we were unable to measure the thickness of the retinal nerve fiber layer for confirmation. Further studies to better assess the status of the overlying retinal nerve fiber layer may be warranted in the future as technology improves. Some patients may present with mild outer retinal discontinuity of the temporal macula and others may present with outer retinal loss, subretinal cavitation resembling subretinal fluid, and significant choroidal excavation. Overall, only one case report described choroidal neovascularization in association with torpedo maculopathy in our review, and that case was stabilized with a series of three intravitreal bevacizumab injections. On color imaging, torpedo lesions classically presented in the temporal macula, just temporal to the fovea. Torpedo maculopathy generally spared the foveola, although subfoveal cases were reported. The nasal aspects of the torpedo lesions were generally pointed or rounded and were usually sharply demarcated without hyperpigmentation, possibly indicating a point of origin. The temporal aspects, on the other hand, were non-binary and frequently presented with irregular pigmentation and/or hyperpigmentation. Temporal aspects were rounded, irregular, frayed or non-solitary. In general, the irregular pigmentation and relative hyperpigmentation associated with the temporal aspects were found to be variable. Four reported cases were found to exhibit nasal hyperpigmentation and irregular borders and all four failed to rule out other prominent differential diagnoses and were therefore excluded from analysis.[8], [11], [12], [13] Although bilateral cases of torpedo maculopathy are presumed to be possible, the only bilateral case reported in the literature, that was not part of a global syndrome, was one of the excluded reports. This bilateral case presented with decreased visual acuity attributed to the lesions, clear visibility of the choroidal vasculature, circumferential hyperpigmentation and circumferential border irregularity, which is not consistent with torpedo maculopathy. The second case excluded presented as a completely hyperpigmented lesion of the RPE in the macula with circumferential border irregularity and a progressive pseudo-lacuna, which is not consistent with torpedo maculopathy. The third case excluded presented with decreased visual acuity attributed to the lesion, temporal macular dragging, disorganization of the inner retina, circumferential border irregularity, and irregular hyperpigmentation, which is not consistent with torpedo maculopathy. The fourth case excluded presented with decreased visual acuity attributed to the lesion, clear visibility of the choroidal vasculature, circumferential hyperpigmentation and circumferential border irregularity, which is not consistent with torpedo maculopathy. Common differential diagnoses to consider when confronted with a macular lesion include toxoplasmosis (or chorioretinal scar from another unknown etiology), toxocariasis, macular coloboma, congenital hypertrophy of the retinal pigment epithelium (CHRPE) and combined hamartoma of the retina and RPE. The major differentiating factors between these lesions and torpedo maculopathy were the presence of 360-degree hyperpigmentation with irregular borders, clear visualization of the choroidal vasculature, reduction of visual acuity attributed to a lesion, macular dragging, and central macular location. The finding of 360-degree hyperpigmentation with irregular borders is most commonly seen in inflammatory conditions with chorioretinal scarring. Clear visualization of the choroid is typically seen in conditions such as chorioretinal scarring and macular colobomas. Reduction in visual acuity attributed to a lesion is commonly seen in conditions that specifically affect the fovea, including chorioretinal scarring, macular coloboma, or macular combined hamartoma of the retina and RPE. Macular dragging has not been associated with torpedo maculopathy, but it can be seen in conditions such as toxocariasis and combined hamartoma of the retina and RPE. Other syndromes associated with torpedo-like lesions include Turcot syndrome, Gardner syndrome, and congenital Zika virus infection.

Conclusion

Torpedo maculopathy is presumed to be a congenital lesion of the RPE that can affect the outer retina and choroid. Distribution mapping analysis of torpedo lesions supports a congenital etiology and suggests a role of the retinal nerve fiber layer in the proper development of mature RPE. Torpedo lesions are generally oval-shaped and sharply demarcated with a longer horizontal length compared to the vertical. They orient toward the optic disc along the horizontal raphe and localize to a kite-shaped region of the temporal macula, correlating with the anatomic junction of the superior arcuate, inferior arcuate, and papillomacular bundles. Torpedo maculopathy is often hypopigmented and sharply demarcated nasally and characteristically variable with pigmentary changes temporally. Most lesions are asymptomatic and rarely involve the foveal center. Patients almost always maintain excellent visual acuity, but visual field defects on formal testing are possible. When presented with a questionable oval-shaped lesion, it is important to consider other differential diagnoses including toxoplasmosis (or chorioretinal scar from another unknown etiology), toxocariasis, macular coloboma, combined hamartoma of the retina and RPE, CHRPE, Turcot syndrome, Gardner syndrome, and Zika virus infection.

Conflict of interest

The authors report no conflict of interest.

Financial Support

National Eye Institute Core Grant P30 EY006360.
  44 in total

1.  Three cases of a rare congenital abnormality of the retinal pigment epithelium: torpedo maculopathy.

Authors:  Michela Rigotti; Silvia Babighian; Elisabetta Carcereri De Prati; Giorgio Marchini
Journal:  Ophthalmologica       Date:  2002 May-Jun       Impact factor: 3.250

2.  Torpedo maculopathy at the site of the fetal "bulge".

Authors:  Carol L Shields; Juan M Guzman; Michael J Shapiro; Lisa E Fogel; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2010-04

3.  Novel optical coherence tomography classification of torpedo maculopathy.

Authors:  Evan N Wong; Samantha Fraser-Bell; Alex P Hunyor; Fred K Chen
Journal:  Clin Exp Ophthalmol       Date:  2014-11-07       Impact factor: 4.207

4.  Two case reports of torpedo maculopathy.

Authors:  K Schuerch; A Ebneter; M Zinkernagel
Journal:  Klin Monbl Augenheilkd       Date:  2015-04-22       Impact factor: 0.700

5.  Spectral-domain optical coherence tomography and fundus autofluorescence evaluation of torpedo maculopathy.

Authors:  Akshay S Thomas; Christina J Flaxel; Mark E Pennesi
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2015-03-13       Impact factor: 1.402

6.  Torpedo maculopathy: in-vivo histology using optical coherence tomography.

Authors:  Timothy Tsang; Leonard V Messner; Andrew Pilon; Lorraine Lombardi
Journal:  Optom Vis Sci       Date:  2009-12       Impact factor: 1.973

7.  The formation of the axonal pattern in the embryonic avian retina.

Authors:  W Halfter; S Deiss; U Schwarz
Journal:  J Comp Neurol       Date:  1985-02-22       Impact factor: 3.215

8.  Torpedo Maculopathy Associated with Choroidal Neovascularization.

Authors:  D Jurjevic; C Böni; D Barthelmes; K Fasler; M Becker; S Michels; J Stemmle; C Herbort; S A Zweifel
Journal:  Klin Monbl Augenheilkd       Date:  2017-05-03       Impact factor: 0.700

9.  Torpedo maculopathy.

Authors:  Pamela R Golchet; Lee M Jampol; Jeevan R Mathura; Mark J Daily
Journal:  Br J Ophthalmol       Date:  2009-10-12       Impact factor: 4.638

Review 10.  Distinguishing torpedo maculopathy from similar lesions of the posterior segment.

Authors:  Victor M Villegas; Stephen G Schwartz; Harry W Flynn; Hilda Capó; Audina M Berrocal; Timothy G Murray; J William Harbour
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2014-04-17       Impact factor: 1.300

View more
  4 in total

1.  Clinical evaluation of torpedo maculopathy in an infant population with additional genetic testing for NEXMIF mutation.

Authors:  Gokhan Celik; Murat Gunay; Asli Vural; Osman Kizilay; Yasemin Kendir Demirkol; Muhammet Kazim Erol
Journal:  Eye (Lond)       Date:  2021-07-29       Impact factor: 4.456

2.  Congenital ocular toxoplasmosis with torpedo maculopathy and retinopathy of prematurity in a premature baby.

Authors:  Darakhshanda Khurram; Syed M Ali; Quan Dong Nguyen; Igor Kozak
Journal:  Am J Ophthalmol Case Rep       Date:  2021-05-13

3.  Letter to the editor: Torpedo Maculopathy: A case series - insights into basic pathology.

Authors:  Diya Baker; Intesar Nur
Journal:  Eur J Ophthalmol       Date:  2020-09-15       Impact factor: 2.597

4.  Multimodal Imaging of Torpedo Maculopathy With Fluorescence Adaptive Optics Imaging of Individual Retinal Pigmented Epithelial Cells.

Authors:  Kari V Vienola; Kunal K Dansingani; Andrew W Eller; Joseph N Martel; Valerie C Snyder; Ethan A Rossi
Journal:  Front Med (Lausanne)       Date:  2021-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.